Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• Citi reiterates Buy rating on AMD with $575 price target post TMT conference
• Tenable to integrate Anthropic's Claude into its security platform